Skip to main content
IMS Events Main banner

    Michael D. Amatangelo, PhD

    Scientific Director, Translational Medicine
    Bristol Myers Squibb, Summit, NJ, USA
    Summit, New Jersey

    Michael D. Amatangelo, PhD, is a Scientific Director of Translational Medicine at Bristol Myers Squibb, based in Summit, New Jersey. He currently serves as the late-stage translational development lead for the Iberdomide and Mezigdomide programs in Multiple Myeloma. Dr. Amatangelo earned his PhD in Molecular Cell Biology and Genetics from Drexel University College of Medicine in Philadelphia, Pennsylvania, and completed his postdoctoral fellowship at The Wistar Institute at the University of Pennsylvania.

    Disclosure information not submitted.

    Presentation(s):